## **Core Concept**
Hyperammonemia type I, also known as carbamyl phosphate synthetase I (CPS I) deficiency, is a urea cycle disorder. The urea cycle is crucial for removing excess ammonia from the body through conversion to urea. This process primarily occurs in the liver.

## **Why the Correct Answer is Right**
The correct answer, carbamyl phosphate synthetase I (CPS I), is an enzyme critical for the initiation of the urea cycle in the liver. CPS I catalyzes the synthesis of carbamoyl phosphate from ammonia, bicarbonate, and ATP. A deficiency in CPS I leads to an inability to properly process ammonia, resulting in hyperammonemia. This condition manifests with severe symptoms, including neurological impairment and can be life-threatening if not promptly treated.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Ornithine transcarbamylase (OTC) deficiency is associated with hyperammonemia type II. OTC is another enzyme in the urea cycle that catalyzes the transfer of a carbamoyl group from carbamoyl phosphate to ornithine, producing citrulline. While OTC deficiency does lead to hyperammonemia, it is not type I.
- **Option B:** Argininosuccinate synthetase deficiency leads to citrullinemia, a different urea cycle disorder. This enzyme catalyzes the condensation of citrulline with aspartate to form argininosuccinate. Its deficiency results in hyperammonemia but through a different mechanism than CPS I deficiency.
- **Option D:** Arginase deficiency is associated with hyperargininemia, another urea cycle disorder but one that presents with spastic diplegia and other neurological symptoms. Arginase catalyzes the hydrolysis of arginine to urea and ornithine, the final step of the urea cycle.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that patients with urea cycle disorders like CPS I deficiency often present with symptoms of hyperammonemia, including confusion, disorientation, and in severe cases, coma. Early diagnosis and treatment, which may include dietary restrictions, medications to reduce ammonia levels, and in some cases, liver transplantation, are critical for improving outcomes.

## **Correct Answer:** . Carbamyl phosphate synthetase I.